HgCapital sells Mercury Pharma to Cinven
HgCapital has sold Mercury Pharma, the UK-based speciality pharmaceutical company, to Cinven, the European private equity firm, for GBP465m. Following the sale of Mercury Pharma, 20 per cent of invested capital will have been realised by the HgCapital 2009 vintage fund, HgCapital 6. Since the start of the global economic